KKPCFOTCHealthcare · Drug Manufacturers - Specialty & Generic

Kaken Pharmaceutical Co., Ltd.

$26.00+0.00%(+$0.00)

TickerSpark Score

50/100

Mixed

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KKPCF research report →

52-Week Range64% of range

Low $22.30

Current $26.00

High $28.12

Companywww.kaken.co.jp

Kaken Pharmaceutical Co. , Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.

CEO: Hiroyuki Horiuchi
IPO: 2020
Employees: 1,135
HQ: Tokyo, JP

Price Chart

-7.44% · this period

Valuation

Market Cap: $984.58M
P/E: 72.98
P/S: 2.03
P/B: 1.06
EV/EBITDA: 29.71
Div Yield: 4.60%

Profitability

Gross Margin: 52.02%
Op Margin: -1.17%
Net Margin: 2.79%
ROE: 1.46%
ROIC: -0.52%

Growth & Income

Revenue: $77.35B · -17.74%
Net Income: $2.16B · -84.53%
EPS: $57.52 · -84.26%
Op Income: $-904,658,701
FCF YoY: -155.79%

Performance & Tape

52W High: $28.12
52W Low: $22.30
50D MA: $26.00
200D MA: $25.92
Beta: 0.13
Avg Volume: 9.764

Get TickerSpark's AI analysis on KKPCF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime